411 related articles for article (PubMed ID: 6339196)
1. Calcium antagonists. Pharmacokinetic properties.
Kates RE
Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.
Echizen H; Eichelbaum M
Clin Pharmacokinet; 1986; 11(6):425-49. PubMed ID: 3542336
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of diltiazem and other calcium entry blockers.
Hermann P; Morselli PL
Acta Pharmacol Toxicol (Copenh); 1985; 57 Suppl 2():10-20. PubMed ID: 3904330
[TBL] [Abstract][Full Text] [Related]
4. [Clinical pharmacology of calcium antagonists].
Lauterburg BH
Schweiz Med Wochenschr; 1987 Mar; 117(13):496-501. PubMed ID: 3576161
[TBL] [Abstract][Full Text] [Related]
5. [Clinical pharmacology of calcium inhibitors].
Singlas E; Martre H; Taburet AM
Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():15-22. PubMed ID: 3937500
[TBL] [Abstract][Full Text] [Related]
6. Calcium-channel blocking agents.
Leonard RG; Talbert RL
Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of calcium channel antagonists.
McAllister RG
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S340-5. PubMed ID: 6184565
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of calcium-entry blockers.
McAllister RG; Hamann SR; Blouin RA
Am J Cardiol; 1985 Jan; 55(3):30B-40B. PubMed ID: 3881917
[TBL] [Abstract][Full Text] [Related]
9. Update on calcium-channel blocking agents.
Talbert RL; Bussey HI
Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of calcium antagonists: a critical review.
Eichelbaum M; Echizen H
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S963-7. PubMed ID: 6085385
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and dynamics of calcium entry antagonists in systemic hypertension.
McAllister RG; Schloemer GL; Hamann SR
Am J Cardiol; 1986 Feb; 57(7):16D-21D. PubMed ID: 3513512
[TBL] [Abstract][Full Text] [Related]
12. Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles.
Pang DC; Sperelakis N
Eur J Pharmacol; 1983 Feb; 87(2-3):199-207. PubMed ID: 6601581
[TBL] [Abstract][Full Text] [Related]
13. Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine.
Pearigen PD; Benowitz NL
Drug Saf; 1991; 6(6):408-30. PubMed ID: 1793522
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of verapamil.
Hamann SR; Blouin RA; McAllister RG
Clin Pharmacokinet; 1984; 9(1):26-41. PubMed ID: 6362951
[TBL] [Abstract][Full Text] [Related]
15. Ca(2+)-channel blockers and nucleoside triphosphate diphosphohydrolase (NTPDase) influence of diltiazem, nifedipine, and verapamil.
Gendron FP; Latour JG; Gravel D; Wang Y; Beaudoin AR
Biochem Pharmacol; 2000 Dec; 60(12):1959-65. PubMed ID: 11108813
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetic profile of amlodipine.
Abernethy DR
Am Heart J; 1989 Nov; 118(5 Pt 2):1100-3. PubMed ID: 2530866
[TBL] [Abstract][Full Text] [Related]
17. [Interaction between calcium antagonists and digoxin].
Christensen C
Ugeskr Laeger; 1991 Apr; 153(17):1180-4. PubMed ID: 2028527
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and metabolism of bepridil.
Benet LZ
Am J Cardiol; 1985 Mar; 55(7):8C-13C. PubMed ID: 3872057
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of calcium antagonists under development.
Abernethy DR; Schwartz JB
Clin Pharmacokinet; 1988 Jul; 15(1):1-14. PubMed ID: 3042243
[TBL] [Abstract][Full Text] [Related]
20. Clinical differentiation of nifedipine and other calcium antagonists.
Ebner F; Donath M; Rämsch KD
Arq Bras Cardiol; 1984 Jul; 43(1):5-12. PubMed ID: 6395839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
